The increasing legalization of prescription opioids has resulted in a surge in opioid abuse, leading to a growing demand for alexipharmic drugs. As per reports, the global alexipharmic drug market is valued at a staggering USD 3.80 billion in 2024, and it is predicted to reach USD 6.50 billion by 2034, growing at a CAGR …
Continue reading “Global Alexipharmic Drug Market is expected to reach USD 6.50 Billion by 2034”